These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 18281245)

  • 21. Effect of hormones on matrix metalloproteinases gene regulation in human aortic smooth muscle cells.
    Grandas OH; Mountain DJ; Kirkpatrick SS; Rudrapatna VS; Cassada DC; Stevens SL; Freeman MB; Goldman MH
    J Surg Res; 2008 Jul; 148(1):94-9. PubMed ID: 18570937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas.
    Maruo T; Ohara N; Matsuo H; Xu Q; Chen W; Sitruk-Ware R; Johansson ED
    Contraception; 2007 Jun; 75(6 Suppl):S99-103. PubMed ID: 17531625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
    Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
    Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes.
    He S; Prasanna G; Yorio T
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3737-45. PubMed ID: 17652746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata.
    Chwalisz K; Larsen L; Mattia-Goldberg C; Edmonds A; Elger W; Winkel CA
    Fertil Steril; 2007 Jun; 87(6):1399-412. PubMed ID: 17307170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata.
    Chwalisz K; DeManno D; Garg R; Larsen L; Mattia-Goldberg C; Stickler T
    Semin Reprod Med; 2004 May; 22(2):113-9. PubMed ID: 15164306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells.
    Yamada T; Nakago S; Kurachi O; Wang J; Takekida S; Matsuo H; Maruo T
    Hum Reprod; 2004 Apr; 19(4):815-21. PubMed ID: 15033949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells.
    Wang J; Ohara N; Takekida S; Xu Q; Maruo T
    Hum Reprod; 2005 Jun; 20(6):1456-65. PubMed ID: 15760954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy.
    Wilkens J; Chwalisz K; Han C; Walker J; Cameron IT; Ingamells S; Lawrence AC; Lumsden MA; Hapangama D; Williams AR; Critchley HO
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4664-71. PubMed ID: 18765509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
    Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
    Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.
    Chen L; Nakai M; Belton RJ; Nowak RA
    Reproduction; 2007 Feb; 133(2):405-14. PubMed ID: 17307908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of matrix metalloproteinase-1, matrix metalloproteinase-2 and extracellular metalloproteinase inducer in human periodontal ligament cells stimulated with interleukin-1 beta.
    Xiang J; Li C; Dong W; Cao Z; Liu L
    J Periodontal Res; 2009 Dec; 44(6):784-93. PubMed ID: 19602123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy.
    Naruse K; Lash GE; Innes BA; Otun HA; Searle RF; Robson SC; Bulmer JN
    Hum Reprod; 2009 Mar; 24(3):553-61. PubMed ID: 19088110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
    J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
    Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
    Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study.
    Hirano H; Tsuji M; Kizaki T; Sashikata T; Yoshi Y; Okada Y; Mori H
    Med Electron Microsc; 2002 Mar; 35(1):16-23. PubMed ID: 12111403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular matrix metalloproteinase inducer (EMMPRIN) is increased in human left ventricle after acute myocardial infarction.
    Nie R; Xie S; Du B; Liu X; Deng B; Wang J
    Arch Med Res; 2009 Oct; 40(7):605-11. PubMed ID: 20082877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of collagen prolyl 4-hydroxylase and matrix metalloproteinases in fibrosarcoma cells by hypoxia.
    Fähling M; Perlewitz A; Doller A; Thiele BJ
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):119-26. PubMed ID: 15556073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.